Recent advances in the use of ZFN-mediated gene editing for human gene therapy.

ABSTRACT: Targeted genome editing with programmable nucleases has revolutionized biomedical research. The ability to make site-specific modifications to the human genome, has invoked a paradigm shift in gene therapy. Using gene editing technologies, the sequence in the human genome can now be precisely engineered to achieve a therapeutic effect. Zinc finger nucleases (ZFNs) were the first programmable nucleases designed to target and cleave custom sites. This article summarizes the advances in the use of ZFN-mediated gene editing for human gene therapy and discusses the challenges associated with translating this gene editing technology into clinical use.

SUBMITTER: Chandrasegaran S 

PROVIDER: S-EPMC5736148 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature